Biology, Genetics, and Diagnosis
At a Glance
PAPA syndrome is diagnosed by combining the pattern of joint and skin flares with evidence that joint inflammation is not caused by bacteria, plus CRP and ESR results and PSTPIP1 testing. A pathogenic variant supports the diagnosis, while a negative or uncertain result requires specialist review.
Getting to a diagnosis of PAPA syndrome is often a process of elimination. Because the condition is so rare, it is frequently mistaken for more common illnesses. Understanding the biology behind the syndrome and the tools doctors use to identify it can help you make sense of a journey that often feels like a series of confusing test results.
A Case of Mistaken Identity
The most common hurdle in diagnosing PAPA syndrome is how closely it mimics a severe bacterial infection.
- Septic Arthritis: This is an infection in a joint caused by bacteria. In both septic arthritis and PAPA syndrome, a joint becomes swollen, red, and filled with white blood cells [1][2]. Because a bacterial infection is a medical emergency, doctors must treat it first with antibiotics and often procedure to drain the joint. When these treatments fail to resolve the issue, and when lab cultures repeatedly show no bacteria, doctors may begin to suspect PAPA syndrome [1][3]. (However, it is important to remember that cultures can sometimes be falsely negative, especially if antibiotics were already given, which is why clinical judgment is always required).
- Juvenile Idiopathic Arthritis (JIA): Many children are initially diagnosed with JIA because they have persistent joint inflammation [4]. However, unlike typical JIA, PAPA syndrome flares are often more abrupt and may not respond well to standard JIA treatments. The diagnosis often shifts to PAPA once the characteristic skin ulcers or severe acne appear later on [5][6].
The Biology of the PSTPIP1 Gene
At the heart of PAPA syndrome is a variation in the PSTPIP1 gene [7]. This gene is responsible for creating a protein that acts like a regulator for your innate immune system.
In PAPA syndrome, certain pathogenic variants (mutations) in the PSTPIP1 protein enhance its interaction with another protein called pyrin. This interaction promotes the activation of the inflammasome—a molecular complex that drives inflammation [7][8].
This dysregulation leads to the overproduction of powerful chemical messengers, primarily Interleukin-1 beta (IL-1β), which signals the body to create inflammation [9]. Another marker, Interleukin-18 (IL-18), has also been found at elevated levels in some patients, though it is not routinely used as a diagnostic test [7][10]. These chemicals draw neutrophils (a type of white blood cell) into your joints and skin even though there is no infection, creating the intensely inflammatory fluid seen during flares [11][12].
Inheritance and Family Planning
PAPA syndrome is generally an autosomal dominant condition. This means:
- You only need to inherit one copy of the mutated gene (from either parent) to develop the disorder.
- If you carry a disease-causing PSTPIP1 variant, each of your children has a 50% chance of inheriting it.
- However, the disease has “variable expression,” meaning symptoms can differ greatly even between a parent and child; one might have severe arthritis, while the other only has skin issues.
- Some cases occur de novo, meaning the mutation happened spontaneously in the patient and was not inherited from either parent.
If you or your child receives a diagnosis, it is highly recommended to speak with a genetic counselor to understand what this means for other family members.
The Diagnostic Workup
To evaluate for PAPA, your medical team looks at several pieces of evidence:
Blood Tests and Joint Fluid
During a flare, blood tests will usually show high levels of inflammation, with elevated markers like CRP (C-reactive protein) and ESR (erythrocyte sedimentation rate) [2][13]. If a joint is swollen, a doctor may perform an aspiration to draw fluid. In PAPA, this fluid is packed with neutrophils but remains sterile (shows no bacterial growth in the lab) [1][2].
Decoding Genetic Results
Genetic testing for the PSTPIP1 gene is helpful, but it requires careful specialist interpretation.
- Pathogenic Variants: If your report labels a variant as “pathogenic” or “likely pathogenic,” and your symptoms match, it strongly supports the diagnosis [14].
- Variants of Uncertain Significance (VUS): Often, genetic testing finds a change in the gene that has never been seen before. A VUS should NOT be used to confirm or rule out the disease [14]. Doctors must look at the patient’s symptoms and family history, and sometimes perform additional testing, to decide what the variant means [15].
- Mutation-Negative Presentations: Some patients have symptoms that look exactly like PAPA syndrome but do not have an identifiable mutation in the PSTPIP1 gene [10]. A negative test does not guarantee you have the same underlying biology, and mutation-negative presentations require careful reassessment for alternative diagnoses by an experienced specialist.
Because of these complexities, PAPA is a clinical diagnosis built on your history of symptoms, the exclusion of true infections, and supporting evidence from genetics and lab tests [4][14].
Common questions in this guide
How can PAPA syndrome look like a bacterial joint infection?
What do PSTPIP1 genetic test results mean in PAPA syndrome?
Is PAPA syndrome inherited by children?
What tests help doctors diagnose PAPA syndrome during a flare?
How is PAPA syndrome distinguished from juvenile idiopathic arthritis?
Should my family have genetic testing after a PAPA syndrome diagnosis?
Get notified when new evidence is published on PAPA syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Clinical and Genetic Findings of the First Report of PAPA Syndrome in Brazil.
Fernandes SJ, Valdomir Nadaf MI, Monteiro NH, et al.
Case reports in immunology 2021; (2021()):6660937 doi:10.1155/2021/6660937.
PMID: 34938582 - 2
[Targeted therapy of pyogenic sterile arthritis, pyoderma gangrenosum, and acne syndrome (PAPA): a case report and literature review].
Liang WL, Li HG, Zhong G, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2020; (58(12)):977-981 doi:10.3760/cma.j.cn112140-20200430-00456.
PMID: 33256319 - 3
Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome in a Chinese family: A case report and review of literature.
Lu LY, Tang XY, Luo GJ, et al.
World journal of clinical cases 2021; (9(22)):6393-6402 doi:10.12998/wjcc.v9.i22.6393.
PMID: 34435004 - 4
Case Report: Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne: A Single-Center Experience and Literature Review.
Wang Y, Wu N, Yu K, Shen M
Frontiers in immunology 2021; (12()):735851 doi:10.3389/fimmu.2021.735851.
PMID: 34745107 - 5
PAPA Syndrome: Challenges in Achieving Long-Term Remission.
Smajlović H, Prohić A
Acta dermatovenerologica Croatica : ADC 2023; (31(2)):106-109.
PMID: 38006373 - 6
Novel PSTPIP1 gene mutation in a patient with pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome.
Lindwall E, Singla S, Davis WE, Quinet RJ
Seminars in arthritis and rheumatism 2015; (45(1)):91-3.
PMID: 25845478 - 7
Interrupting an IFN-γ-dependent feedback loop in the syndrome of pyogenic arthritis with pyoderma gangrenosum and acne.
Lee W, Stone DL, Hoffmann P, et al.
Annals of the rheumatic diseases 2024; (83(6)):787-798 doi:10.1136/ard-2023-225085.
PMID: 38408849 - 8
The Relationship between NALP3 and Autoinflammatory Syndromes.
Campbell L, Raheem I, Malemud CJ, Askari AD
International journal of molecular sciences 2016; (17(5)).
PMID: 27187378 - 9
Disease activity accounts for long-term efficacy of IL-1 blockers in pyogenic sterile arthritis pyoderma gangrenosum and severe acne syndrome.
Omenetti A, Carta S, Caorsi R, et al.
Rheumatology (Oxford, England) 2016; (55(7)):1325-35 doi:10.1093/rheumatology/kew031.
PMID: 26989109 - 10
Excess Serum Interleukin-18 Distinguishes Patients With Pathogenic Mutations in PSTPIP1.
Stone DL, Ombrello A, Arostegui JI, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2022; (74(2)):353-357 doi:10.1002/art.41976.
PMID: 34492165 - 11
Dysregulated neutrophil responses and neutrophil extracellular trap formation and degradation in PAPA syndrome.
Mistry P, Carmona-Rivera C, Ombrello AK, et al.
Annals of the rheumatic diseases 2018; (77(12)):1825-1833 doi:10.1136/annrheumdis-2018-213746.
PMID: 30131320 - 12
Pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome: differential diagnosis of septic arthritis by regular detection of exceedingly high synovial cell counts.
Löffler W, Lohse P, Weihmayr T, Widenmayer W
Infection 2017; (45(4)):395-402 doi:10.1007/s15010-017-0996-1.
PMID: 28251506 - 13
A de novo heterozygous PSTPIP1 variant associated with PAPA syndrome: a Chinese case report and literature review.
Wang M, Zhang P, Shen M
Frontiers in genetics 2026; (17()):1825761 doi:10.3389/fgene.2026.1825761.
PMID: 42358432 - 14
Phenotypic Associations of PSTPIP1 Sequence Variants in PSTPIP1-Associated Autoinflammatory Diseases.
Boursier G, Piram M, Rittore C, et al.
The Journal of investigative dermatology 2021; (141(5)):1141-1147 doi:10.1016/j.jid.2020.08.028.
PMID: 33218716 - 15
PAPA and FMF in two siblings: possible amplification of clinical presentation? A case report.
Maggio MC, Ceccherini I, Grossi A, et al.
Italian journal of pediatrics 2019; (45(1)):111 doi:10.1186/s13052-019-0705-z.
PMID: 31443670
This page explains PAPA syndrome biology and diagnosis for informational purposes only and does not replace medical advice. Your medical team and a genetic counselor should interpret your symptoms, cultures, and PSTPIP1 results.